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ABSTRACT
Aim: To evaluate smoking and COPD prevalence amongst
teachers working in the schools of Kocaeli City, Turkey. 
Method: In this cross-sectional study, a questionnaire focusing
on respiratory symptoms and smoking habits was adminis-
tered to all participants who accepted to join the study. All sub-
jects also underwent a physical examination and a pulmonary
function test performed with portable spirometer. According
to GOLD criteria, subjects who had post-bronchodilator
FEV1/FVC < 70% and negative reversibility test were classi-
fied as COPD. 
Results: A total of 685 teachers were included [female n =
307 (45%), male n = 378 (55%)] with mean age 38.9 ± 8.9
years. Smoking habit was evaluated in 660 subjects: 291
(44.1%) were smokers, 252 (38.2%) were non-smokers and
117 (17.7%) were ex-smokers. Pulmonary function test was
available in 651 subjects and 510 (78.3%) were defined as
normal on spirometric analysis. Small airway obstruction
was found in 115 of the cases (17.7%) in whom FEF25-75 level
was found to be lower than 70% predicted. FEV1/FVC level
was lower than 70% in 16 subjects (2.5%). Five subjects
who had positive reversibility test were excluded from the
study. The remaining 11 subjects who were considered as
COPD consisted of 2 (18%) females and 9 (82%) males. Six
of these subjects were aged over 40 years. 
Conclusion: Spirometry has an important role in early diagno-
sis of COPD. Spirometric evaluation of cases with risk factors
for COPD could be helpful in diagnosing patients before the
progressive decline in lung function begins. Further studies
are needed to evaluate whether the interventional strategies
at this stage such as smoking cessation could prevent the
progression of disease. 
Keywords: COPD, prevalence, spirometry.
RIASSUNTO 
Scopo: Valutare la prevalenza di tabagismo e bronchite croni-
ca ostruttiva (BPCO) tra gli insegnanti delle scuole di Kocaeli
City in Turchia.
Metodi: Studio trasversale per il quale è stato distribuito un
questionario incentrato sui sintomi respiratori e sull’abitudi-
ne tabagica a tutti i partecipanti che hanno accettato di pren-
dere parte allo studio. Tutti i soggetti si sono sottoposti ad
una visita e ad una spirometria effettuata con uno spirometro
portatile. Sono stati classificati come BPCO, sulla base dei cri-
teri GOLD, i soggetti che avevano dopo broncodilatatore un
rapporto FEV1/FVC < 70% e non presentavano reversibilità.
Risultati: Sono stati inclusi 685 insegnanti [femmine n = 307
(45%), maschi n = 378 (55%)] con un’età media di 38,9 ± 8,9
anni. In 600 soggetti è stata valutata l’abitudine al fumo: 291
(44,1%) erano fumatori, 252 (38,2%) non fumatori e 117
(17,7%) ex-fumatori. La spirometria era disponibile in 651
soggetti e 510 (78,3%) avevano una spirometria normale.
Un’ostruzione delle piccole vie è stata riscontrata in 115 casi
(17,7%), individuati per il valore di FEF25-75 < 70% del teorico.
Il rapporto FEV1/FVC era < 70% in 16 soggetti (2,5%). Cinque
soggetti che hanno mostrato una broncoreversibilità sono
stati esclusi dallo studio. I rimanenti 11 soggetti che sono per-
ciò stati considerati come BPCO risultavano composti da 2
(18%) femmine e 9 (82%) maschi. Sei di questi soggetti ave-
vano un’età superiore a 40 anni.
Conclusioni: La spirometria riveste un ruolo importante nella
diagnosi precoce di BPCO. Una valutazione spirometrica dei
casi con fattori di rischio per BPCO potrebbe essere di aiuto
nel riuscire a fare diagnosi prima che inizi la progressione del
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declino della funzionalità respiratoria. Ulteriori studi sono ne-
cessari per valutare se le strategie di intervento in questo sta-
dio, come la cessazione del fumo, possano prevenire la pro-
gressione della malattia.
Parole chiave: BPCO, prevalenza, spirometria.    
INTRODUCTION 
Chronic obstructive pulmonary disease (COPD) is a
preventable and treatable disease characterized by
chronic progressive airflow limitation that is not ful-
ly reversible. As a global health problem, COPD is
a major cause of morbidity and mortality world-
wide. Today, COPD ranks 6th among all causes of
death and it is projected to be the 3rd leading cause
of death in 2020 [1].
COPD prevalence is below 1% in all age groups ac-
cording to the World Health Organization [2].
Recently, parallel with increased smoking rates and
a progressive aging of the population, COPD preva-
lence has risen progressively [3]. The increase of to-
bacco marketing strategies in developing countries
has caused COPD prevalence to rise worldwide [4].
Smoking is the most important risk factor for COPD.
Since the majority of smokers start smoking at ado-
lescent age, influence of society is very important at
this period. Adolescents are influenced by friends
and teachers who are role-models for them [5].
Therefore, smoking attitudes of teachers are espe-
cially important for our future generations and for
the achievement of the goal of a smoke-free popu-
lation. Unfortunately, although the data are limited,
recent studies have found that smoking rates in
teachers in Turkey were from 36.2% to 52.4% [6-
10]. As a result of this high smoking rate, it was
thought that COPD prevalence might be high in
teachers. The aim of this study was to evaluate
smoking and COPD prevalence amongst teachers
working in the schools of Kocaeli City. 
MATERIALS AND METHODS
Study population
In this cross-sectional population-based study,
teachers who accepted to join the study and could
perform an acceptable spirometer maneuver were
included in the study. Cases that did not have ap-
propriate questionnaire data or could not perform
an acceptable spirometer maneuver were excluded
from the study. 
Study design
Teachers who work in Kocaeli were informed about
the study aim and design. In this prospective study,
the European Community Respiratory Health
Survey (ECRHS) questionnaire [11] investigating
respiratory symptoms and smoking habits was ad-
ministered to all participants who accepted to join
the study. All subjects underwent a physical exami-
nation and a pulmonary function test was per-
formed with portable spirometer (Koko Legend
portable spirometer; Ferraris Med, Co, USA).
Spirometer calibration was checked daily with a 
3-L syringe. 
The pulmonary function test was performed accord-
ing to American Thoracic Society (ATS) criteria by a
trained technician with participants in a seated 
position [12]. Participants performed up to 8 forced
expiratory maneuvers to obtain three acceptable
maneuvers (difference between largest and second
largest values < 200 ml for both forced expiratory
volume in 1 sec [FEV1] and forced vital capacity
[FVC]). If the participants were tired or had not an
acceptable maneuver, the test was stopped. 
Values of FVC, FEV1, FEV1/FVC, forced expiratory
flow (FEF)25-75 were evaluated in the pulmonary
function test. Patients with airflow limitation
(FEV1/FVC < 70%) received four puffs (100 mcg
each) of salbutamol sulfate administered via a spacer
(Volumatic®) and spirometry was performed after 20
minutes. An increase by 12% or 200 ml of the post-
bronchodilator FEV1 value with respect to baseline
FEV1 was defined as reversible [1,13,14]. Cases
with reversible airway obstruction and a history
suggestive of asthma were excluded while cases
that had irreversible airway obstruction were ac-
cepted as COPD and medical treatment and follow
up were planned for them. Spirometry was evaluat-
ed as small airway obstruction if FEF25-75 level was
lower than 70% predicted. Cases that had FEV1/FVC
ratio greater than 70% with a FVC level lower than
80% predicted were defined as restrictive. 
The study was approved by the Kocaeli University
Medical Faculty Ethics Committee and all subjects
gave their informed consent. 
Case definitions
COPD: Post-bronchodilator FEV1/FVC of less than
70% without reversibility was accepted as COPD
whether there were respiratory symptoms or not. 
Chronic bronchitis: It was defined as cough and
sputum production for at least 3 months of 2 con-
secutive years. 
Asthma: Cases with reversible airway obstruction
were accepted as asthmatic if their history was con-
sistent with asthma, and they were excluded from
the analysis. 
Subjects with reversible airflow obstruction without
respiratory complaints and subjects with chronic
respiratory symptoms with normal lung function
were invited to our out-patient clinic for further in-
vestigation, and excluded from the analysis.
Furthermore all smokers were recommended to a
smoking cessation clinic after medical advice to
quit smoking. 
Statistical analysis
Statistical analysis was performed with the SPSS
13.0 program. Data are reported as mean ± stan-
dard deviation. Student’s t test and Mann Whitney-
U test were used to compare data between groups.
Chi-square test was used for the comparison of rates































A total of 685 teachers were included in the study.
Of these 307 were female (45%) and 378 were
male (55%). Mean age was 38.9 ± 8.9 years, and
296 subjects (43.2%) were over the age of 40. The
mean age and the number of cases older than 40
years were significantly higher in males than fe-
males. Demographic data of the study population is
shown in Table I. 
Smoking habits were evaluated in 660 subjects, of
which 291 (44.1%) were smokers, 252 (38.2%)
non-smokers, and 117 (17.7%) ex-smokers. The
percentage of current smokers was 43.2% in fe-
males and 44.8% in males. There was no statistical-
ly significant difference between male and female
smokers (p = 0.6). 
It was found that 161 subjects (23.5%) had a smok-
ing history over 10 years (103 men, 58 women).
There was a statistically significant difference be-
tween genders for smoking history over 10 years 
(p = 0.001).
The mean number of cigarettes smoked in a day
was 5.7 ± 8.9 (min: 1, max: 40) and there was a sta-
tistically significant difference between genders
(males 6.5 ± 9.9, females 4.7 ± 7.3, p = 0.001). In
the study there was a considerably large range in
the number of cigarettes smoked. So the standard
deviation was higher than average. It was found that
76 male (21.3%) and 34 female (11.5%) smokers
had a daily consumption of cigarettes over 20.
Smoking characteristics according to gender are
shown in Table II. 
Chronic bronchitis was found in 23 of 631 partici-
pants (3.8%) and 73.9% of these cases were smok-
ers. There was a statistically significant difference in
smoking rates between chronic bronchitis and non-
chronic bronchitis cases (p = 0.007). Only two of
the chronic bronchitis cases were diagnosed as
COPD. No significant relation was found with
COPD.
Pulmonary function tests were available in 651 sub-
jects and 510 of them (78.3%) were defined as nor-
mal spirometric analysis. Mean values of FEV1 and
FEF25-75 revealed a significant difference between
genders (FEV1 % predicted: male 100.9 ± 14.6 vs.
female 98.6 ± 13.0, p = 0.03; FEF25-75 %: male 94.4
± 25.9 vs. female 83.6± 20.7, p=0.001). Small air-
way obstruction was found in 115 subjects (17.7%)
in whom FEF25-75 level was found to be lower than
70% predicted. Comparison of pulmonary function
tests between males and females is shown in Table
III.
FEV1/FVC level was lower than 70% in 16 subjects
(2.5%). Five subjects who had a positive reversibil-
ity test were excluded from the study. The remaining
11 subjects (6 of whom were aged over 40) were
considered as COPD and consisted of 2 females
(18%) and 9 males (82%) (Table IV). All of the cases
diagnosed as COPD were current or ex-smokers. 
DISCUSSION
This study demonstrates high smoking rates and a
considerably high prevalence of COPD in a rela-
tively young population consisting of teachers. 
Different COPD definitions can influence the re-
ported prevalence rates. COPD prevalence varies
according to epidemiologic definition [17,18] and
the local variability of risk factors and other un-
known conditions [19,20]. 
The global burden of COPD was evaluated in a sys-
tematic meta-analysis by Halbert and co-workers.
The most common spirometric definition was that
of GOLD and the pooled prevalence of COPD was
7.6% from 37 studies [21]. 
Lindberg et al. evaluated COPD prevalence among
TABLE I: DEMOGRAPHIC CHARACTERISTICS 
OF PARTICIPANTS 
Total Female Male P
n (%) 685 307 (45%) 378 (55%) 0.007
Age, mean (years) 38.9 ± 8.9 35.9 ± 7.9 41.3 ± 9 0.001
(min: 18, (min: 20,
max: 58) max: 70)
≥ 40 years, n (%) 296 (43.2%) 92 (30%) 204 (54%) 0.001
Body mass index, 23.7 ± 6.7 21.8 ± 6.4 25.1 ± 6.6 0.9
mean (Kg/m2)
TABLE II: SMOKING CHARACTERISTICS ACCORDING 
TO GENDER  
Total Female Male P
Smoker, n (%) 291 (44.1%) 128 (43.2%) 163 (44.8%) 0.6
Non-smoker, n (%) 252 (38.2%) 131 (44.3%) 121 (33.2%) 0.5
Ex-smoker, n (%) 117 (17.7%) 37 (12.5%) 80 (22%) 0.001
Smoking history 161 (23.5%) 58 (20.8%) 103 (30%) 0.001
≥ 10 years, n (%)
Number 5.7 ± 8.9 4.7 ± 7.3 6.5 ± 9.9 0.001
of cigarettes/ (max: 40)
day, mean
TABLE III: COMPARISON OF PULMONARY FUNCTION TESTS
BETWEEN MALES AND FEMALES   
Total Female Male P
FVC (% pred.) 102.4 ± 13.9 102.7 ± 13.5 102.1 ± 14.2 0.6
FEV1 (% pred.) 99.8 ± 14.1 98.6 ± 13.3 100.9 ± 14.6 0.03
FEV1/FVC (%) 101.4 ± 10.3 100.5 ± 9.4 101.5 ± 11 0.1
FEF25-75 (% pred.) 89.6 ± 24.3 83.6 ± 20.7 94.4 ± 25.9 0.001
Definition of abbreviations: FVC, forced vital capacity; FEV1, forced
expiratory volume in 1 sec.; FEF, forced expiratory flow. 
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666 participants aged 20-69 years. COPD preva-
lence was 7.6, 14, 14.1, 12.2, and 34.1% according
to, respectively, British Thoracic Society (BTS),
European Respiratory Society (ERS), GOLD, clinical
and spirometric ATS criteria. Prevalence of COPD
was related to age and smoking habits but not to
gender [22]. 
Menezes et al. evaluated COPD prevalence accord-
ing to symptoms, GOLD and ERS criteria. They
showed that chronic bronchitis prevalence by ques-
tionnaire data was 7.8% and COPD prevalence was
15.2% according to GOLD. COPD was higher
among men, elderly and ex-smokers [15]. 
The PREPOCOL study evaluated COPD prevalence
for different altitudes, in 5 Colombian cities. 
A respiratory questionnaire was administered and
pre-post bronchodilator spirometry performed in
5,539 participants who were over 40 years of age.
The overall COPD prevalence was 8.9, 2.8, 3.2%
using the spirometric, medical and clinical defini-
tions. The factors related to COPD were age over 60
years, male gender, smoking and low educational
level. The overall prevalence of active smoking was
18.3%, higher in men (24.4%) than in women
(15.3%) [16]. 
In our study, COPD was defined by clinical and
spirometric data according to GOLD criteria.
Chronic bronchitis symptoms were found in 23 of
631 participants (3.8%), a finding in line with
Caballero et al. Our study’s COPD prevalence ac-
cording to GOLD was 2%, which was lower than
other studies. But smoking prevalence in our study
was higher than that of Caballero et al. and there
was no difference between male and female gen-
der.
Recently, the Burden of Lung Disease (BOLD) as-
sessment was created for a standardized evaluation
of the burden of COPD. The BOLD questionnaire
included information on respiratory symptoms and
risk factors for COPD and pre-post bronchodilator
spirometry performed in BOLD studies. The
Australian BOLD study included 1,258 participants
older than 40 years of age, and the overall preva-
lence of COPD at stage I and higher was found to
be 26.1%, similar in males and females. Smoking
prevalence was 19.2% and also showed no differ-
ence between genders [13]. In the BOLD study in
Iceland (ISOLD study), COPD prevalence was 18%,
and there was no difference between males and fe-
males. The prevalence of COPD increased with age
and the amount of tobacco smoked [23]. The BOLD
study carried out in Poland’s Mapolska region
showed that COPD prevalence was 22.1% and
higher in men than women. Smoking prevalence
was 28% (males: 36.1%, females: 21.9%) [14]. In
the BOLD study in China, 20,245 participants com-
pleted both a questionnaire and spirometry. The
overall prevalence of COPD was 8.2% (males:
12.4%, females: 5.1%) [24]. 
In our study, the method used to detect COPD - a
questionnaire that included respiratory symptoms
and smoking habits and post-bronchodilator
spirometry performed in each participant – was
similar to that of the BOLD studies. Also COPD def-
inition was according to GOLD criteria. But the
COPD prevalence found in our study (2%) was low-
er than that of BOLD studies. This might be related
to our limited study population.
COPD prevalence is 0.934% in men, 0.733% in
women (all age groups) according to the World
Health Organization [3]. Recently, in parallel with
increased smoking rates and the growing age of the
population, COPD prevalence is rising progressive-
ly [4]. Furthermore it was thought that the increase
of COPD prevalence in women was related to in-
creased smoking rates. While there were no differ-
ences in COPD prevalence between gender in
some of these studies [13,22,23], in our study
COPD prevalence was higher in men than in
women, in agreement with other studies [14-
16,24]. 
Epidemiologic data on COPD are limited in our
country. In particular, there are no data on occupa-
tion and COPD. COPD prevalence, risk factors and
burden of disease were evaluated in the Adana
BOLD study by Kocabaş et al. in the period
December 2003-January 2004. Preliminary results
of this study showed that COPD prevalence was
about 20% in subjects over 40 years of age in
Adana [25]. 
Örnek et al. evaluated 611 participants who were 
> 18 years of age by respiratory questionnaire and
spirometry (evaluated according to GOLD criteria)
in order to determine the prevalence of COPD in
Zonguldak. COPD prevalence was found to be
15.2% in the overall population and it was 17.8%
regarding the subjects > 40 years of age [26]. 
Günen et al. evaluated COPD prevalence in a popu-
lation randomly selected from urban and rural regions
of Malatya. Through a respiratory questionnaire and
post-bronchodilator spirometry performed in 1,160
participants over the age of 18, COPD prevalence
was found to be 6.9%. While the prevalence of
COPD was 18.1% in current smokers, the prevalence
was 4.5% among young smokers. Biomass exposure
was significantly common (54.5%) among female
subjects living in rural areas. Smoking prevalence was
57.2% in men, 25.5% in women [27].
In our study, COPD prevalence (2%) was found to
be lower than in other studies carried out in our
country. This might be related to the fact that our
TABLE IV: PULMONARY FUNCTION TEST RESULTS 
ACCORDING TO GENDER   
Total Female Male P
n (%) n (%) n (%)
Normal 510 (78.3) 217 (74.3) 293 (81.7) 0.001
Obstruction 16 (2.5) 5 (1.7) 11 (3) 0.4
Restriction 10 (1.5) 4 (1.4) 6 (1.7) 0.5






























6 study population features one occupational group
and so may not project all characteristics of society.
When COPD prevalence was evaluated according
to gender, we found a male predominance, a simi-
lar result to other studies in our country. But, in con-
trast to Günen et al., smoking prevalence was simi-
lar in both males and females in our study. 
In conclusion, COPD is a preventable and treatable
disease. Spirometry has an important role in early
diagnosis of COPD. Spirometric evaluation of cases
with risk factors for COPD could be helpful to diag-
nose patients before the progressive decline in lung
function begins. Further studies are needed to eval-
uate whether interventional strategies at this stage
such as smoking cessation could prevent the pro-
gression of disease. 
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